Navigation Links
BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008
Date:9/4/2008

SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the fourth quarter and full fiscal year ended June 30, 2008. Net sales were $16.7 million for the quarter ended June 30, 2008 as compared to $15.4 million for the quarter ended June 30, 2007, an increase of $1.3 million or 8.4%. The net loss was $20.0 million for the quarter ended June 30, 2008 as compared to a net loss of $4.9 million for the quarter ended June 30, 2007. Net sales were $67.5 million for fiscal year 2008 as compared to $47.4 million for fiscal year 2007, an increase of $20.1 million or 42.4%. The net loss was $29.5 million for the fiscal year 2008 as compared to $13.6 million for fiscal year 2007. The $20.0 million net loss in the fourth quarter and the $29.5 million net loss for fiscal year 2008 each included an $11.2 million charge for acquired in-process research and development arising from the purchase of substantially all assets of Advanced Cosmetic Intervention, Inc. (ACI) in April 2008.

Operating Results:

Domestic sales were $13.2 million for the quarter ended June 30, 2008 as compared to $12.7 million for the quarter ended June 30, 2007, an increase of $0.5 million or 3.9%. International sales were $3.5 million for the quarter ended June 30, 2008, as compared to $2.6 million for the quarter ended June 30, 2007, an increase of $0.9 million or 34.6%. Gross profit was $14.4 million for the quarter ended June 30, 2008 as compared to $12.4 million for the quarter ended June 30, 2007, an increase of $2.0 million, or 16.1%. As a percentage of sales, gross profit for the quarter ended June 30, 2008 was 86.3% as compared to 81.1% for the quarter ended June 30, 2007. The increase
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 2014 Emerging Nuclear Power Countries - ... , Summary , The latest report from GlobalData, Emerging ... Development Analysis to 2030 covers the emerging nuclear market ... comprehensive information on key market players and their global ... various countries across the world has also been estimated. ...
(Date:7/18/2014)... -- The International Wheat Genome Sequencing Consortium (IWGSC) published ... of the bread wheat genome. The chromosome-based draft provides ... the large, complex genome of the world,s most widely ... an invaluable resource to plant science researchers and breeders. ... a set of tools enabling them to rapidly locate ...
(Date:7/18/2014)... Littleton, MA (PRWEB) July 18, 2014 ... Ph.D. to its growing Advisory Board. Dr. Vaught ... science for over 20 years. As one of ... for Biological and Environmental Repositories - in 1999, he ... he is again president-elect. , In 2005, Dr. Vaught ...
(Date:7/17/2014)... MOUNTAIN VIEW, Calif. , July 17, 2014 /PRNewswire-iReach/ ... preclinical research, today announced the addition of David ... interventionalist, and Benigno Mills , a veterinary surgical ... addition, to better serve our clients, we are pleased ... on Twitter , Facebook and ...
Breaking Biology Technology:Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 3
... to Apply for Incentive Program, RALEIGH, N.C., ... around the Research Triangle Area (RTA) who provide ... the RTA Health Care,Collaborative, a group of forward-thinking ... is implementing an initiative,known as the Bridges to ...
... SAN FRANCISCO, Calif., Aug. 16 Anesiva,Inc. (Nasdaq: ... in the,Zingo(TM) development program before the markets open ... held at 8:30 a.m. Eastern Time,tomorrow to discuss ... the live audio webcast by dialing,800-340-6289 (international dial: ...
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today ... the U.S. Food and Drug Administration (FDA) for,VALSTAR(R). ... is the only product approved by the FDA ... (CIS) of the,urinary bladder. VALSTAR was removed ...
Cached Biology Technology:Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 2Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 3Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs 4Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4
(Date:7/21/2014)... of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the ... the virus. The work, published this week in ... Society for Microbiology, indicates that further studies are needed ... the air. , MERS, a serious viral respiratory illness ... people as of June 11, according to the World ...
(Date:7/21/2014)... every movement, researchers have shown for the first time ... farms and pipelines. Those man-made structures probably serve as ... study published in the Cell Press journal Current ... shocked when I first saw the stunning grid pattern ... wind farm in the United Kingdom, says Deborah Russell ...
(Date:7/21/2014)... 2014 Dysfunction in dopamine signaling profoundly changes ... the brain,s prefrontal cortex and may be an ... as schizophrenia, according to UC Irvine scientists. , ... cells that receive this neurotransmitter showed for the ... variety of behavioral and physiological functions regulated in ...
Breaking Biology News(10 mins):Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2Seals forage at offshore wind farms 2UCI researchers find epigenetic tie to neuropsychiatric disorders 2
... Horizon oil spill temporarily worsened existing manmade problems in Louisiana,s ... for optimism, according to a new study. A study ... Academy of Sciences found the 2010 spill killed off ... and this plant die off resulted in a more-than-doubled rate ...
... Older women with insufficient levels of Vitamin D gained more weight ... new study funded by the National Institutes of Health and published ... study of more than 4,600 women ages 65 and older found ... D in their blood gained about two pounds more than those ...
... The international project LEGATO (Land-use intensity ... and Opportunities in irrigated rice based production systems) ... Ecosystem Services and Ecological Engineering" which will be ... 7 July. LEGATO unites 21 research institutions ...
Cached Biology News:BP Deepwater Horizon oil spill exacerbated existing environmental problems in Louisiana marshes 2BP Deepwater Horizon oil spill exacerbated existing environmental problems in Louisiana marshes 3Low vitamin D levels linked to weight gain in some older women 2
... Conjugated peptides or recombinant proteins are used ... antibodies in 2 rabbits. pre-immune and three ... until the titer reaches 1:4,000 Western blot ... G purification Antibodies are eluted using both ...
... analysis & visualization software. ... multiple samples. Combine Sequest ... increased confidence. Get more ... from your MS/MS experiments.14 ...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: